Qiagen NV (NYSE:QGEN)
$ 45.47 -0.22 (-0.48%) Market Cap: 10.09 Bil Enterprise Value: 10.75 Bil PE Ratio: 30.13 PB Ratio: 2.80 GF Score: 85/100

Qiagen NV at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 12:30PM GMT
Release Date Price: $39.46 (+0.84%)
Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst

Good morning. My name is Peter Welford, I'm the European biopharma and life sciences analyst at Jefferies in London. And it's my great pleasure to introduce the next company in this track, which is QIAGEN. And it's my great pleasure to have here from QIAGEN today, Peer Schatz, CEO; and Jonathan Arnold as well. Jonathan Arnold (inaudible) I say that he runs Precision Diagnostics, I believe, and results for QIAGEN as well. So it's a fireside chat. I've obviously got questions. Please do raise the hand and actually we'll put over a mic somewhere around here, we'll get a mic out to you as well and happy then by all means for anyone to take any questions from the audience. So with that, over to Peer, and thank you very much.

Peer Michael Schatz
QIAGEN N.V. - CEO, MD & Member of Management Board

Well, thanks, Peter. It's a pleasure to be here. We just came from ASCO, which is the largest cancer conference in the world, 50,000 oncologists swarmed in on Chicago once a year, and it has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot